This week's trade

This week’s pick is a global healthcare giant with a long history of innovation.

The company just reported stronger than expected earnings for Q2 and raised its fiscal year (FY) 2025 earnings per share (EPS) guidance… Resulting in one of the best trading days it had in 2 years.

Despite losing over a billion dollars in sales due to some patent expirations, which are now in the rear view mirror, the company’s CFO reported that one of their business segments grew 15.5% year-over-year to a record $15.2 billion in Q2 2025.

All of this is signaling a breakout for this well-known company.

Join Wall Street Unplugged Premium for full analysis and ticker symbol